Capecitabine as an alternative in a case of fluorouracil-induced photodermatitis [8]

Clinical Oncology

Volumn 18, Issue 2, 2006, Pages 158-159

  Tsoussis, S ^a   Vourliotaki, I ^a   Ekonomidou, F ^a   Apostolakis, S ^a  

^a Venizelion General Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID;

AGED; BOLUS INJECTION; CASE REPORT; DRUG CLEARANCE; DRUG POTENTIATION; EPIPHORA; EYE TOXICITY; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; PHOTODERMATOSIS; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; RECTUM CARCINOMA; SKIN DEFECT; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; PHOTOSENSITIVITY DISORDERS; RECTAL NEOPLASMS;

EID: 31644437626     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.12.001     Document Type: Letter

References (5)

1. S. Leo C. Tatulli R. Taveri G.A. Campanella G. Carrieri G. Colucci Dermatological toxicity from chemotherapy containing 5-fluorouracil J Chemother 6 1994 423-426
2. E. Chu A.C. Mota M. Fogarasi Antimetabolites T. DeVita Jr. S. Hellman S.A. Rosenberg Cancer, principles and practice of oncology 6th edn. 2001 Lippincott Williams and Wilkins Philadelphia, PA 388-415
3. M. Miwa M. Ura M. Nishida et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur J Cancer 34 1998 1274-1281
4. A. Willey E.J. Glusac J.L. Bolognia Photoeruption in a patient treated with capecitabine (Xeloda) for metastatic breast cancer J Am Acad Dermatol 47 2002 453
5. M. Mackean A. Planting C. Twelves et al. Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer J Clin Oncol 16 1998 2977-2985